Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for BioMarin Pharmaceutical Inc. (BMRN)

« Back to company index

BMRN Chatter Timeline

Stock Ticker for BMRN

Most Active Tweeters for BMRN

UserTweets
@_B_I_O_T_E_C_H_ 18
@dteb16 11
@johnscharts 8
@Optionminer 6
@Gambiste1 6

Recent Tweets for BMRN

bbnsnews @bbnsnews
$0.23 EPS Expected for BioMarin Pharmaceutical Inc. $BMRN This Quarter https://t.co/wL25qgOTLP
4:01am
EnterpriseLeade @EnterpriseLeade
BioMarin Pharmaceutical Inc. $BMRN Expected to Post Earnings of $0.23 Per Share https://t.co/hkO6GsBGzf
4:01am
AmericanBanking @AmericanBanking
BioMarin Pharmaceutical Inc. $BMRN Expected to Post Earnings of $0.23 Per Share https://t.co/8pIqjSPY4V #stocks
4:01am
newsfilterio @newsfilterio
BioMarin mulling price of $2M - 3M for hemophilia gene therapy $BMRN https://t.co/OYvbIqob9o
1:01am
dakotafinancial @dakotafinancial
BioMarin Pharmaceutical $BMRN Downgraded by Zacks Investment Research to Sell https://t.co/6GVztBvU8U
January 19th 2020, 11:01am
newsfilterio @newsfilterio
BioMarin Pharmaceutical Downgraded by Zacks Investment Research to Sell $BMRN https://t.co/zz3ALZbyGO
January 19th 2020, 11:01am
stocknewstimes @stocknewstimes
BioMarin Pharmaceutical $BMRN Downgraded by Zacks Investment Research to Sell https://t.co/gAkXAbp3Eg
January 19th 2020, 11:01am
newsfilterio @newsfilterio
Analysts Set BioMarin Pharmaceutical Price Target at $111.63 $BMRN https://t.co/QJm97zBLle
January 19th 2020, 10:01am
stocknewstimes @stocknewstimes
Analysts Set BioMarin Pharmaceutical Inc. $BMRN Price Target at $111.63 https://t.co/JO3vvZ3MEm
January 19th 2020, 9:01am
EnterpriseLeade @EnterpriseLeade
Jean Jacques Bienaime Sells 8,000 Shares of BioMarin Pharmaceutical Inc. $BMRN Stock https://t.co/i2f1yRT6bi
January 19th 2020, 5:01am
ThisLincolnian @ThisLincolnian
Jean Jacques Bienaime Sells 8,000 Shares of BioMarin Pharmaceutical Inc. $BMRN Stock https://t.co/jnKsKh5mxT
January 19th 2020, 4:01am
OlympiaReport @OlympiaReport
BioMarin Pharmaceutical $BMRN Cut to “Sell” at Zacks Investment Research https://t.co/ldluxtJQ80
January 18th 2020, 10:01am
WeekHerald @WeekHerald
BioMarin Pharmaceutical $BMRN Rating Lowered to Sell at Zacks Investment Research https://t.co/vRWSdiNAJL
January 18th 2020, 10:01am
Gambiste1 @Gambiste1
RT @dteb16: @BuyOnStrength $BMRN Valrox strategy is a marketing one, not a efficacy-based one. Scare all the patients into using Valrox…
January 18th 2020, 12:01am
TranscriptDaily @TranscriptDaily
BioMarin Pharmaceutical $BMRN Stock Rating Lowered by Zacks Investment Research https://t.co/lYu597XtOD
January 17th 2020, 12:01pm
TLS_Pete @TLS_Pete
$BMRN what a disappointment this week, had high hopes for this company going into JPM healthcare summit. Just seems… https://t.co/LfA3N9Gfc0
January 17th 2020, 10:01am
TickerReport @TickerReport
Insider Selling: BioMarin Pharmaceutical Inc. $BMRN CEO Sells 8,000 Shares of Stock https://t.co/HOK1ezuZQ7
January 17th 2020, 4:01am
ZolmaxNews @ZolmaxNews
Jean Jacques Bienaime Sells 8,000 Shares of BioMarin Pharmaceutical Inc. $BMRN Stock https://t.co/riWcleNZdW
January 17th 2020, 4:01am
AmericanBanking @AmericanBanking
Insider Selling: BioMarin Pharmaceutical Inc. $BMRN CEO Sells 8,000 Shares of Stock https://t.co/jEiHaqOA6O #stocks
January 17th 2020, 4:01am
endpts @endpts
BioMarin execs discuss some eye-popping numbers for the price of valrox — but haven't we heard this before? https://t.co/uMarr44lv2 $BMRN
January 17th 2020, 3:01am
InsiderAlertsIA @InsiderAlertsIA
$BMRN: New Insider Filing on Chief Executive Officer JEAN JACQUES BIENAIME: https://t.co/YAa95bZHmg
January 16th 2020, 8:01pm
StockTexts @StockTexts
$BMRN BioMarin Pharmaceutical Inc. SEC Filing: Form 4 https://t.co/twaC0vvynu
January 16th 2020, 8:01pm
MonitorAction @MonitorAction
$BMRN Jean Jacques Bienaime Dumps 8K Shares of BIOMARIN PHARMACEUTICAL INC https://t.co/Z2rN331bPV
January 16th 2020, 8:01pm
JohnCendpts @JohnCendpts
BioMarin execs discuss some eye-popping numbers for the price of valrox -- but haven't we heard this before? $BMRN' https://t.co/lPCvjLhVkA
January 16th 2020, 5:01pm
StckPro @StckPro
$BMRN NEW ARTICLE : BioMarin Considers $3 Million Price Tag for New Hemophilia Gene Therapy https://t.co/Fa85e5raKx… https://t.co/dKmBIYVaYj
January 16th 2020, 5:01pm
HealthcareEcon1 @HealthcareEcon1
@walidgellad @hedgeclip save $bmrn
January 16th 2020, 4:01pm
BiotechAnalysst @BiotechAnalysst
RT @mchilberg: Glad to hear it. Check out the timeline for each in my article which clearly shows $BMRN trading patient efficacy for lead…
January 16th 2020, 3:01pm
TouTzuSays @TouTzuSays
$BMRN - BioMarin mulling price of $2M - 3M for hemophilia gene therapy https://t.co/vOal7SFYYK
January 16th 2020, 2:01pm
biotechinvestor @biotechinvestor
RT @MarketCurrents: $BMRN - BioMarin mulling price of $2M - 3M for hemophilia gene therapy https://t.co/WoOjx66VDS
January 16th 2020, 2:01pm
MarketCurrents @MarketCurrents
$BMRN - BioMarin mulling price of $2M - 3M for hemophilia gene therapy https://t.co/WoOjx66VDS
January 16th 2020, 2:01pm
AmericanBanking @AmericanBanking
BioMarin Pharmaceutical Inc. $BMRN Receives Average Rating of “Buy” from Analysts https://t.co/MrXAUw5t8t #stocks
January 16th 2020, 1:01pm
dteb16 @dteb16
@doc4care Can’t be understated, especially in context vs $BMRN Valrox $SGMO
January 16th 2020, 12:01pm
mchilberg @mchilberg
Glad to hear it. Check out the timeline for each in my article which clearly shows $BMRN trading patient efficacy… https://t.co/3ry0oPADyl
January 16th 2020, 12:01pm
heyjt55 @heyjt55
RT @Biotech2050: $SGMO vs $BMRN #hemophilia #genetherapy Per @SangamoTx CEO: Predictability and reliability are key features of SB-525
January 16th 2020, 11:01am
heyjt55 @heyjt55
RT @Biotech2050: $SGMO CEO reprimands $BMRN on aggressive marketing and not putting patients' interest first.
January 16th 2020, 11:01am
JassimBinhazeem @JassimBinhazeem
@Biotech2050 @_B_I_O_T_E_C_H_ So $sgmo asking $bmrn to wait for their results ????? very nice move
January 16th 2020, 11:01am
Biotech2050 @Biotech2050
$SGMO CEO reprimands $BMRN on aggressive marketing and not putting patients' interest first.
January 16th 2020, 11:01am
Biotech2050 @Biotech2050
$SGMO vs $BMRN #hemophilia #genetherapy Per @SangamoTx CEO: Predictability and reliability are key features of SB-525
January 16th 2020, 11:01am
TranscriptDaily @TranscriptDaily
BioMarin Pharmaceutical Inc. $BMRN Short Interest Update https://t.co/Y3wrRCpg9U
January 15th 2020, 4:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: @mchilberg arrogant $BMRN ceo with his big mouth... when i look as this rapid downhill plateau: " can your factor leve…
January 15th 2020, 2:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
@mchilberg arrogant $BMRN ceo with his big mouth... when i look as this rapid downhill plateau: " can your factor l… https://t.co/28CDDDbb62
January 15th 2020, 2:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @mchilberg: Just a reminder for $BMRN investors that believe the adoption rate projections within 5 yrs for #Valrox: The factor activit…
January 15th 2020, 2:01pm
mchilberg @mchilberg
Just a reminder for $BMRN investors that believe the adoption rate projections within 5 yrs for #Valrox: The facto… https://t.co/Nt5cO0FEFZ
January 15th 2020, 2:01pm
BiotechAnalysst @BiotechAnalysst
RT @dteb16: Time for analysts to start baking this $SGMO $BMRN #hemophilia outcome probability into their models. @ProfMakris knows what he…
January 15th 2020, 2:01pm
dteb16 @dteb16
@BobbyKingRules @_B_I_O_T_E_C_H_ I am just saying I don’t think $BMRN marketing strategy is going to work. Hemophil… https://t.co/SCZdyTZmWN
January 15th 2020, 10:01am
MP_Fitzgerald @MP_Fitzgerald
RT @OphirGottlieb: 4/n $NVTA Remarkable example of how partnership w $BMRN radically changed the dynamic of how kids 0-8 years old get dia…
January 15th 2020, 10:01am
OphirGottlieb @OphirGottlieb
4/n $NVTA Remarkable example of how partnership w $BMRN radically changed the dynamic of how kids 0-8 years old ge… https://t.co/lLq7LwpRfX
January 15th 2020, 10:01am
dteb16 @dteb16
@_B_I_O_T_E_C_H_ Street starting to appreciate it w/ $PFE (price) which could unleash M&A. And oh $BMRN is really g… https://t.co/8sEOifKYVc
January 15th 2020, 10:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @dteb16: @_B_I_O_T_E_C_H_ I don’t think $BMRN strategy on dosing the entire HemA market with an inferior product at a premium price, sol…
January 15th 2020, 9:01am
biotech_junkie @biotech_junkie
RT @_B_I_O_T_E_C_H_: $BMRN first shot @ hemophilia A but waning level of response leaves few analysts wondering whether $SGMO in particular…
January 15th 2020, 9:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.